A self-controlled case series to assess the effectiveness of beta blockers for heart failure in reducing hospitalisations in the elderly

BMC Medical Research Methodology

Volumn 11, Issue , 2011, Pages

  Ramsay, Emmae N ^a   Roughead, Elizabeth E ^b   Ewald, Ben ^c   Pratt, Nicole L ^b   Ryan, Philip ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; CLINICAL TRIAL (TOPIC); EVALUATION; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; METHODOLOGY; STATISTICS; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 79960555832     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-11-106     Document Type: Article

References (21)

1. A review of uses of health care utilization databases for epidemiologic research on therapeutics. Schneeweiss S, Avorn J, Journal of Clinical Epidemiology 2005 58 323 337 10.1016/j.jclinepi.2004.10.012 15862718 (Pubitemid 40601980)
2. The Risk of Fractures Associated with Thiazolidinediones: A Self-controlled Case-Series Study. Douglas IJ, Evans SJ, Pocock S, Smeeth L, PLoS Medicine 2009 6 9 1000154 10.1371/journal.pmed.1000154 19787025
3. Confounding Control in Healthcare Database Research Challenges and Potential Approaches. Brookhart MA, Sturmer T, Glynn R, Rassen J, Schneeweiss S, Med Care 2010 48 114 S120 20473199
4. The contribution of observational studies to the knowledge of drug effectiveness in heart failure. Dobre D, van Veldhuisen DJ, deJongste MJL, van Sonderen E, Klungel OH, Sanderman R, Ranchor AV, Haaijer-Ruskamp FM, British Journal of Clinical Pharmacology 2007 64 4 406 414 10.1111/j.1365-2125.2007. 03010.x 17764473 (Pubitemid 47404319)
5. The methodology of self-controlled case series studies. Whitaker HJ, Hocine MC, Farrington CP, Statistical Methods in Medical Research 2009 18 7 26 10.1177/0962280208092342 18562396
6. Tutorial in Biostatistics: The self-controlled case series method. Whitaker HJ, Farrington CP, Spiessens B, Musonda P, Statistics in Medicine 2005 0 1 31
7. Post-Marketing Studies of Drug Efficacy: How? Strom B, Miettinen O, Melmon K, Am J Med 1984 77 703 708 10.1016/0002-9343(84)90369-3 6486146 (Pubitemid 14047604)
8. Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke and death. Hubbard R, Lewis S, Smith C, Godfrey C, Smeeth L, Farrington P, Britton J, Tobacco Control 2005 14 416 421 10.1136/tc.2005.011387 16319366 (Pubitemid 41759617)
9. Exposure to antipsychotics and risk of stroke: self controlled case series study. Douglas IJ, Smeeth L, BMJ 2008 337 a1227 1 5
10. Use of the Self-controlled Analytical Techniques to Assess the Association Between Use of Prescription Medications and the Risk of Motor Vehicle Crashes. Gibson J, Hubbard R, Smith C, Tata L, Britton J, Fogarty A, Am J of Epidemiol 2009 169 6 761 768 10.1093/aje/kwn364
11. Risk of Hospitalization for Stroke Associated with Antipsychotic Use in the Elderly: A Self-Controlled Case Series. Pratt N, Roughead E, Ramsay E, Salter A, Ryan P, Drugs Aging 2010 27 11 885 893 10.2165/11584490-000000000- 00000 20964462
12. Post-marketing assessment of the saftey of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions. Grosso A, Douglas I, Hingorani A, MacAllister R, Smeeth L, Br J Clin Pharmacol 2008 66 5 689 694 18754840
13. Oral Bisphosphonates and Risk of Atrial Fibrillation and Flutter in Women: A Self-Controlled Case-Series Saftey Analysis. Grosso A, Douglas I, Hingorani A, MacAllister R, Smeeth L, PLoS One 2009 4 3 4720 10.1371/journal.pone.0004720 19266096
14. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. Hippisley-Cox J, BMJ 2010 340 2197 10.1136/bmj.c2197 20488911
15. Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. Shibata MC, Flather MD, Wang D, European Journal of Heart Failure 2001 3 351 357 10.1016/S1388-9842(01)00144-1 11378007 (Pubitemid 32895844)
16. Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006. Krum H, Jelinek MV, Stewart S, Sindone A, Atherton JJ, Hawkes AL, MJA 2006 185 10 549 556 17115967 (Pubitemid 44816942)
17. Beta-blockers in chronic heart failure: What have we learned? What do we still need to know? Krum H, Current Opinion in Pharmacology 2003 3 168 174 (Pubitemid 36411241)
18. The Effects of Beta-blockers on Morbibity and Mortality in a Population-Based Cohort of 11, 942 Elderly Patients with Heart Failure. Sin DD, Finlay A, McAlister FA, Am J Med 2002 113 650 656 10.1016/S0002-9343(02)01346-3 12505115 (Pubitemid 36015801)
19. Validity of medication-based co-morbidity indices in the Australian elderly population. Vitry A, Wong SA, Roughead E, Ramsay E, Barratt J, Aust N Z J of Public Health 2009 33 126 130 10.1111/j.1753-6405.2009.00357.x
20. The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure. Packer M, Bristow M, Cohn J, Colucci W, Fowler M, Gilbert E, Shusterman N, The New England Journal of Medicine 1996 334 21 1349 1355 10.1056/NEJM199605233342101 8614419 (Pubitemid 26152713)
21. Semiparametric analysis of case series data. Farrington CPWH, Appl Stat 2006 55 553-94